LWBA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Mesoblast Ltd

Watchlist Manager

Watchlist

Price: 3.58 EUR 0.56% Market Closed

Market Cap: €582.6m

M	Mesoblast Ltd F:LWBA	AU
G	Geron Corp SWB:GON	US
C	Clean Harbors Inc F:CH6	US
A	Atoss Software AG XBER:AOF	DE
C	Capitol Federal Financial Inc F:CFW	US
E	East Japan Railway Co F:EJR0	JP
M	Macy's Inc F:FDO	US
M	M/I Homes Inc F:4MI	US
F	First Majestic Silver Corp F:FMV	CA
	Comstock Inc F:GSP0	US
S	Stora Enso Oyj F:ENUR	FI
	Australia and New Zealand Banking Group Ltd ASX:ANZ	AU
B	Bristol-Myers Squibb Co XHAM:BRM	US
C	Conmed Corp F:EC8	US
I	Illumina Inc F:ILU	US
C	Celanese Corp F:DG3	US
R	Reinet Investments SCA XMUN:RNT	LU
T	Tegna Inc XMUN:GTT	US
A	Air Water Inc F:0AW	JP
	COPT Defense Properties NYSE:CDP	US
G	Garmin Ltd F:GEY	CH
R	Realord Group Holdings Ltd SWB:CUV	HK
	LATAM Airlines Group SA F:LFL	CL

Profitability Summary

Mesoblast Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Negative 3Y Average Gross Margin

-50%

Gross Margin is Increasing

-284% > 58%

Negative Operating Margin

-112%

Negative 3Y Average Operating Margin

-786%

Operating Margin is Increasing

-805% > -112%

Negative Net Margin

-144%

Negative 3Y Average Net Margin

-1.020%

Net Margin is Increasing

-1.081% > -144%

Negative Free Cash Flow Margin

-93%

Negative 3Y Average Free Cash Flow Margin

-601%

Free Cash Flow Margin is Increasing

-672% > -93%

Negative ROE

-18%

Negative 3Y Average ROE

Negative 3Y Average ROIC